X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | LPLA | Arnold Dan H. | Pres, CEO | S - Sale+OE | $277.31 | -5,677 | 142,608 | -4% | -$1,574,289 | |||||
2024-02-26 | LPLA | Sethi Kabir | MD | S - Sale | $266.50 | -1,300 | 10,245 | -11% | -$346,451 | ||||||
2024-02-26 | LPLA | Gates Greg | MD | S - Sale | $266.27 | -11,401 | 19,080 | -37% | -$3,035,697 | ||||||
2024-02-26 | LPLA | Enyedi Matthew | MD | S - Sale | $263.00 | -2,400 | 10,495 | -19% | -$631,200 | ||||||
2024-02-26 | LPLA | Audette Matthew J | CFO, Head of Business Ops | S - Sale | $266.52 | -5,574 | 13,663 | -29% | -$1,485,607 | ||||||
| DM | 2024-02-23 | LPLA | Arnold Dan H. | Pres, CEO | S - Sale+OE | $266.39 | -41,896 | 141,810 | -23% | -$11,160,784 | |||||
| D | 2024-02-20 | LPLA | Enyedi Matthew | MD | S - Sale+OE | $256.94 | -1,381 | 8,634 | -14% | -$354,834 | |||||
| D | 2024-02-20 | LPLA | Arnold Dan H. | Pres, CEO | S - Sale+OE | $256.35 | -10,000 | 133,169 | -7% | -$2,563,512 | |||||
| D | 2024-02-05 | LPLA | Audette Matthew J | CFO, Head of Business Ops | S - Sale+OE | $248.55 | -27,704 | 12,644 | -69% | -$6,885,746 | |||||
2023-11-02 | LPLA | Jambusaria Aneri | MD | S - Sale | $222.37 | -1,930 | 1,802 | -52% | -$429,174 | ||||||
| DM | 2023-09-19 | LPLA | Arnold Dan H. | Pres, CEO | S - Sale+OE | $250.02 | -528 | 145,884 | 0% | -$132,011 | |||||
2023-09-13 | LPLA | Steinmeier Richard | MD | S - Sale | $242.68 | -10,300 | 16,914 | -38% | -$2,499,617 | ||||||
| D | 2023-08-22 | LPLA | Enyedi Matthew | MD | S - Sale+OE | $230.86 | -3,265 | 9,978 | -25% | -$753,758 | |||||
2023-05-04 | LPLA | Glavin William Francis Jr | Dir | P - Purchase | $180.23 | +557 | 22,649 | +3% | +$100,388 | ||||||
2023-02-27 | LPLA | Oroschakoff Michelle | MD | S - Sale | $246.18 | -4,809 | 23,852 | -17% | -$1,183,882 | ||||||
2023-02-27 | LPLA | Larsen Sallie R. | MD | S - Sale | $248.13 | -4,439 | 25,196 | -15% | -$1,101,449 | ||||||
2023-02-27 | LPLA | Audette Matthew J | CFO | S - Sale | $246.17 | -7,111 | 12,644 | -36% | -$1,750,480 | ||||||
2023-02-27 | LPLA | Arnold Dan H. | Pres, CEO | S - Sale | $246.20 | -38,444 | 154,884 | -20% | -$9,464,734 | ||||||
| M | 2023-02-16 | LPLA | Oroschakoff Michelle | MD | S - Sale | $248.98 | -17,773 | 23,327 | -43% | -$4,425,145 | |||||
| D | 2023-02-13 | LPLA | Larsen Sallie R. | MD | S - Sale+OE | $241.84 | -20,519 | 24,555 | -46% | -$4,962,330 | |||||
| D | 2023-02-06 | LPLA | Audette Matthew J | CFO | S - Sale+OE | $239.30 | -20,810 | 12,667 | -62% | -$4,979,733 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |